Emcure Pharmaceuticals Ltd. - PE Ratio

The PE Ratio as of October 2026 (TTM) for Emcure Pharmaceuticals Ltd. (EMCURE.NS) is 33.85

According to Emcure Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 33.85. This represents a change of 19.15% compared to the average of 28.41 of the last 4 quarters.

Emcure Pharmaceuticals Ltd. (EMCURE.NS) Historical PE Ratio (quarterly & annually)

How has EMCURE.NS PE Ratio performed in the past?

The mean historical PE Ratio of Emcure Pharmaceuticals Ltd. over the last ten years is 1.27K. The current 33.85 PE Ratio has changed 167.04% with respect to the historical average. Over the past ten years (40 quarters), EMCURE.NS's PE Ratio was at its highest in in the December 2024 quarter at 44.55. The PE Ratio was at its lowest in in the March 2024 quarter at 0.

Emcure Pharmaceuticals Ltd. (EMCURE.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Emcure Pharmaceuticals Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Emcure Pharmaceuticals Ltd. (EMCURE.NS) Average PE Ratio

How has EMCURE.NS PE Ratio performed in the past?

The current PE Ratio of Emcure Pharmaceuticals Ltd. (EMCURE.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Emcure Pharmaceuticals Ltd. (EMCURE.NS) PE Ratio vs. Peers

How is EMCURE.NS’s PE Ratio compared to its peers?

Emcure Pharmaceuticals Ltd.’s PE Ratio is greater than Cipla Limited (31.31), greater than Dr. Reddy's Laboratories Limited (29.71), greater than Aurobindo Pharma Limited (25.70), greater than Lupin Limited (16.01), greater than Alkem Laboratories Limited (29.12), less than Ipca Laboratories Limited (37.54), less than Torrent Pharmaceuticals Limited (71.65), less than Mankind Pharma Limited (48.09), less than Sun Pharmaceutical Industries Limited (34.91), less than Glenmark Pharmaceuticals Limited (34.41),

Build a custom stock screener for Emcure Pharmaceuticals Ltd. (EMCURE.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emcure Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emcure Pharmaceuticals Ltd. (EMCURE.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emcure Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.